Skip to content
PICO Portalanswers from OpenAlex

Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation

PaperCitations, authors & open-access status

Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation is a paper indexed in PICO Portal from OpenAlex.

How many citations does Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation have?

PICO Portalcitation count

Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation has 87 citations in the OpenAlex counts PICO Portal stores.

When was Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation published?

PICO Portalyear

Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation has 2011 year in the PICO Portal index.

What is the open-access status of Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation?

PICO Portaloa status

Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation has closed oa status in the PICO Portal index.

What is the DOI of Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation?

PICO Portaldoi

The DOI for Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation is on the source record.

What is the PMID of Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation?

PICO Portalpmid

The PMID for Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation is on the source record.

What is the OpenAlex record for Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation?

PICO Portalopenalex

The OpenAlex for Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial